Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC5R | P33032 | 15/20 | 1.00 |
| ▸ | MC1R | Q01726 | 6/20 | 1.00 |
| ▸ | MC3R | P41968 | 10/20 | 0.60 |
| ▸ | MC4R | P32245 | 5/20 | 0.60 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | MMP7 | P09237 | 1/20 | 0.50 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
| ▸ | MMP8 | P22894 | 1/20 | 0.50 |
| ▸ | MMP14 | P50281 | 1/20 | 0.50 |
| ▸ | KCNT1 | Q5JUK3 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29367069 | 1.00 | MC5R (1.00) | MC5RMC1RMC3RMC4RMMP2 | |
| SCHEMBL29459408 | 0.91 | MC5R (0.84) | MC5RMC1RMC3RMC4RMMP2 | |
| SCHEMBL12464197 | 0.81 | MC5R (0.68) | MC5RMC1RMMP2MMP7MMP9 | |
| SCHEMBL12464359 | 0.81 | MC5R (0.68) | MC5RMC1RMMP2MMP7MMP9 | |
| SCHEMBL12464195 | 0.81 | MC5R (0.68) | MC5RMC1RMMP2MMP7MMP9 | |
| SCHEMBL27923213 | 0.79 | KCNT1 (0.66) | MC5RMC1RKCNT1KDM4E | |
| SCHEMBL901464 | 0.79 | KCNT1 (0.66) | MC5RMC1RKCNT1KDM4E | |
| SCHEMBL7932520 | 0.79 | MC1R (0.64) | MC5RMC1RMC3RMC4RMMP2 | |
| SCHEMBL24638062 | 0.77 | MC5R (0.62) | MC5RMC1RMC4RMMP2MMP7 | |
| SCHEMBL19199177 | 0.77 | MC5R (0.62) | MC5RMC1RMC4RMMP2MMP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12042523-B2 | Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof | UNIGEN, INC. (US) | 2024-07-23 | — | — | US | disclosed |
| US-20230201295-A1 | Compositions and Methods for Managing or Improving Bone Disorders, Joint Disorders, Cartilage Disorders, or a Combination Thereof | UNIGEN, INC. (US) | 2023-06-29 | — | — | US | disclosed |
| US-20230190852-A1 | COMPOSITIONS AND METHODS FOR JOINT HEALTH | UNIGEN, INC. (US) | 2023-06-22 | — | — | US | disclosed |
| CN-114854152-B | Resin composition and product thereof | 台光电子材料股份有限公司 | 2023-05-23 | — | — | CN | disclosed |
| US-11554153-B2 | Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof | UNIGEN, INC. (US) | 2023-01-17 | — | — | US | disclosed |
| US-11453771-B2 | Resin composition and article made therefrom | Elite Material Co., Ltd. (TW) | 2022-09-27 | — | — | US | disclosed |
| CN-114854152-A | Resin composition and product thereof | 台光电子材料股份有限公司 | 2022-08-05 | — | — | CN | disclosed |
| US-20220243046-A1 | RESIN COMPOSITION AND ARTICLE MADE THEREFROM | Elite Material Co., Ltd. (TW) | 2022-08-04 | — | — | US | disclosed |
| CN-112800518-B | Stratum surface model correction method utilizing adjacent stratum cross-correlation constraint | 中国地质大学（武汉） | 2022-04-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12042523-B2 | Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof | MATR3, ACACA, COL2A1 | MC5R 2879/4885MC1R 4062/4885MC3R 1499/4885 |
| US-11554153-B2 | Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof | MATR3, ACACA, COL2A1 | MC5R 2879/4885MC1R 4062/4885MC3R 1499/4885 |
| US-20230201295-A1 | Compositions and Methods for Managing or Improving Bone Disorders, Joint Disorders, Cartilage Disorders, or a Combination Thereof | MATR3, ACACA, COL2A1 | MC5R 2879/4885MC1R 4062/4885MC3R 1499/4885 |
| US-20230190852-A1 | COMPOSITIONS AND METHODS FOR JOINT HEALTH | PTGES, PTGES3, PTGES2 | MC5R 3686/4885MC1R 4415/4885MC3R 2617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.